Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
06 septembre 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care06 septembre 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Contacts
Lee Harris Partner Londres, Royaume-Uni Antony Walsh Partner Londres, Royaume-Uni Barri Mendelsohn Partner Londres, Royaume-Uni Rachel Cooper Partner Nottingham, Royaume-Uni Edward M. Tompkin-Haag Partner Londres, Royaume-Uni Kelly Holmes Partner Birmingham, Royaume-Uni Philip Crosbie Partner Leeds, Royaume-Uni Christopher Murray Partner Édimbourg, Royaume-Uni Dernières PublicationsDernières News
Dernières Evénements et formations
legal updates 16 juin 2026 EU Pay Transparency Directive: Job evaluation and classification guideline... legal updates 14 juin 2026 Global Sustainability & ESG Insights - May 2026 legal updates 11 juin 2026 EU Tightens Control Over Critical Raw Materials legal updates 11 juin 2026 EU adopts renewed foreign investment framework actualités 15 juin 2026 Eversheds Sutherland continues European expansion with further strategic pa... actualités 09 juin 2026 Eversheds Sutherland powers 12 key deals for Gresham House Energy Storage F... actualités 04 juin 2026 Next stop, public ownership: Eversheds Sutherland advises DfT on GTR transi... actualités 04 juin 2026 Advising Howden Joinery Group plc on £390m DIY Kitchens acquisition virtual Introduction to Swiss employment law 23 juin 2026 2pm - 5pm (GMT) Virtual virtual UAE - Employment law in the Dubai International Financial Centre 10 septembre 2026 9.30am - 1.30pm (GMT) Virtual in-person Basic foundations of US employment law 17 septembre 2026 9.30am - 4.30pm (GMT) Londres, Royaume-Uni in-person 2026 BDC Roundtable 23 septembre 2026 Washington DC, États-Unis d'Amérique |